What Prompts Indoor Tanners and Nontanners to Undergo Skin Cancer Screening?

Share this content:
Of the survey participants questioned, approximately 16% reported using an indoor tanning device.
Of the survey participants questioned, approximately 16% reported using an indoor tanning device.

Indoor tanners are more likely to undergo skin cancer screenings and begin screenings at an earlier age compared with nontanners, according to a study published in JAMA Oncology.

For this study, researchers analyzed the data of 30,352 adult respondents from the 2015 National Health Interview Survey. Participants were asked if they had ever used an indoor tanning device (eg, sunlamp, sunbed, tanning booth), and were also asked if they had ever undergone head-to-toe skin screening with a healthcare provider and what the cause of the screening was. Demographic data such as age, sex, race/ethnicity, socioeconomic status, sexual orientation, employment status, and marital status were also assessed.

Results showed that a total of 4987 (16.43%) survey participants had used an indoor tanning device, of whom 1077 (21.59%) had tanned in the past year; 1505 (30.18%) indoor tanners and 4951 (19.52%) nontanners had undergone screening for skin cancer. 

Correlates that were significantly associated with screening for both groups were older age, higher household income, patients who seek out online health information, family history of melanoma or skin cancer, very high SPF sunscreen use, and having applied a spray on tan.

Other remaining variables that were significant for screening pertained only to nontanners, including white race, non-Hispanic ethnicity, email use, having a regular physician/clinic, emergency room visits, previous cancer history, no concern about paying medical bills, sun protection, and sunless self-tanning.


Heckman CJ, Handork E, Auerbach MV. Prevalence and correlates of skin cancer screening among indoor tanners and nontanners [published online April 4, 2018]. JAMA Oncol. doi: 10.1001/jamadermatol.2018.0163 

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs